Highlights
IIA supported (ever)
About
Cerebral Assist Device for Neurointensive Care
SynCath Neuroscience is a preclinical-stage medical technology start-up developing ECG-synchronized dynamic ICP-modulation technology. The technology is realized via a disposable, autonomous ICP-modulation probe. The probe is in-dwelling, ECG synchronized, and delivered via an external ventricular drain (EVD)-like catheter. The underlying physical mechanism is that externally superimposed fine-volume perturbations can be used to enhance cerebral blood flow with synchronized deflateinflate actions within each cardiac cycle. SynCath will initially address patients instrumented with an EVD.
Identity
| Name | SynCath NeuroScience |
|---|---|
| Slug | syncath-neuroscience |
| Type / kind | startup |
| Crunchbase ID | syncath-neuroscience |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JqyuMkKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Dec 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ra'anana |
| HQ address | Zarhin St 10, Ra'anana, Israel |
Web & social
| https://www.linkedin.com/company/91486577 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
diagnosticsneurologyecgsurgeonsmedical-devicesneurosurgeryneuroscience
Funding
| Total raised | $920K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}